PHDCCI to Host Welcome Reception for Delhi LG Taranjit Singh Sandhu Chandigarh 3 June ( Ranjeet Singh Dhaliwal ) : The PHD Chamber of Commerce and Industry (PHDCCI), through its Punjab, Haryana and Chandigarh Chapters and the Regional Fashion Tex Tech Forum, will host a Welcome Reception in honour of Sardar Taranjit Singh Sandhu, Hon’ble Lieutenant Governor of Delhi, on June 5 at Hyatt Centric, Chandigarh. The event will feature a special session on “Transforming Growth: Vision, Innovation & Sustainability.” Karan Gilhotra, Chair, PHDCCI Punjab, said the event will provide a platform for industry and government stakeholders to exchange ideas on innovation and growth. Himani Arora, Chair, Regional Fashion Tex Tech Forum, said it reflects PHDCCI’s commitment to strengthening industry-government collaboration. Naveen Seth, Deputy Secretary General, PHDCCI, said the programme will promote dialogue on investment, innovation and sustainable economic development.
Historic milestone in cancer care
HBCH&RC gives new lease of life to 15-year old Leukemia patient with CAR-T therapy
S.A.S.Nagar 3 June ( Ranjeet Singh Dhaliwal ) : The Homi Bhabha Cancer Hospital and Research Centre (HBCH&RC), New Chandigarh, Punjab, has achieved a landmark milestone in pediatric oncology by successfully treating a 15-year-old leukemia patient with advanced Chimeric Antigen Receptor T-cell (CAR-T) therapy. CAR-T (Chimeric Antigen Receptor T-cell) therapy is a personalised cancer immunotherapy in which a patient’s own immune cells are collected and modified in specialised laboratories to recognise and attack cancer cells. These enhanced cells are multiplied and infused back into the body, where they help the immune system target and destroy remaining cancer cells. The launch of the CAR-T programme at HBCH&RC places the institution among a select group of centres in North India equipped with the clinical expertise, infrastructure, and regulatory approvals required to provide this life-saving treatment.
The patient, a 15-year-old boy from Haryana, was diagnosed with Very Early Relapsed B-Cell Precursor Acute Lymphoblastic Leukaemia (BCP-ALL). He had experienced an early relapse of cancer in the bone marrow within months of beginning chemotherapy. After detailed multidisciplinary evaluation, the team at HBCH&RC, New Chandigarh recommended him for CAR-T therapy. “Following a bridging chemotherapy phase to control the disease, the patient underwent leukapheresis — a process in which immune cells are collected from the blood. The cells were then sent for specialised manufacturing. After preparing the patient for treatment, the CAR-T cells were infused. He was closely monitored in our dedicated Bone Marrow Transplant unit and received intensive care during every phase of treatment. The patient has now been discharged home in good health with excellent treatment outcome. This is a moment of immense joy for the entire care team and the patient’s family,” said pediatric oncology consultant Dr Jasmeet Sidhu.
Head of Department of Medical Oncology, Dr Seema Gulia, said, “CAR-T therapy is among the most advanced forms of cancer treatment available today and requires highly specialised infrastructure, expert clinical teams, and round-the-clock monitoring. The journey from collecting a patient’s cells to successfully delivering the therapy involves close coordination and precision at every step. Seeing our young patient return home healthy and hopeful is deeply rewarding for our entire team. Our Medical Oncology Department is equipped with modern treatment facilities like monoclonal antibodies, immunotherapies and targeted therapies for patients with solid tumors as well as hematological malignancies.”Director Dr Ashish Gulia said, “This achievement marks a new chapter in cancer care in the region and reflects our commitment to bringing the latest treatment technologies to patients closer to their homes. HBCH Punjab has state-of-the-art facilities to treat all types of cancers, including rare pediatric tumors, bone and soft tissue tumors and neurological tumors. Our aim is to ensure that patients receive world-class cancer care and advanced treatments at affordable costs, without having to leave the region.”
About the HBCH&RC Punjab
In an endeavor to provide world-class Cancer care to the residents of Punjab and neighbouring states & UTs, Honourable Prime Minister Shri Narendra Modi Ji had dedicated 'Homi Bhabha Cancer Hospital & Research Centre' to the Nation at Mullanpur, New Chandigarh, Sahibzada Ajit Singh Nagar District, Mohali in August, 2022. The Hospital had been built at the cost of over Rs. 660 Crore by Tata Memorial Centre, an aided institute under the Department of Atomic Energy, Government of India.
The cancer hospital is a tertiary care hospital with a 300-bed capacity. It is equipped with modern facilities to treat all types of cancers using every available treatment modality like Surgery, Radiotherapy, Chemotherapy, immunotherapy and Bone marrow transplant. The Hospital functions like a 'hub' of cancer care and treatment in the region, with the 150 bedded hospital in Sangrur functioning as its 'spoke'.
Comments
Post a Comment